参考文献/References:
[1] 雷欣东,于慧,龙琼,等.绝经后骨质疏松症发病机制研究进展[J].中国骨质疏松杂志,2021,27(11):1681-1684.
[2] 中华医学会骨质疏松和骨矿盐疾病分会.原发性骨质疏松症诊疗指南(2022)[J].中国全科医学,2023,26(14):1671-1691.
[3] SALARI N,GHASEMI H,MOHAMMADI L,et al.The glo-bal prevalence of osteoporosis in the world:a comprehensive systematic review and meta-analysis[J].J Orthop Surg Res,2021,16(1):609.
[4] 邱晓萍,刘铠婕,林宇慧,等.骨质疏松症的流行病学、管理与防治研究进展[J].山东医药,2023,63(21):107-111.
[5] 盛玲玲,李先娜,霍金海,等.骨质疏松症动物模型及评价方法研究进展[J].黑龙江中医药,2018,47(6):111-113.
[6] 张奕奋,耿倚云,段莉,等.构建骨质疏松动物模型研究进展[J].生物骨科材料与临床研究,2021,18(2):62-66.
[7] 李彦冉,闫盼盼,苗艳艳,等.骨质疏松动物模型构建进展与应用特点分析[J].中国实验动物学报,2023,31(7):928-934.
[8] LI B,WANG Y,GONG S,et al.Puerarin improves OVX-induced osteoporosis by regulating phospholipid metabolism and biosynthesis of unsaturated fatty acids based on serum metabolomics[J].Phytomedicine,2022,102:154198.
[9] SONG H,POLK J D,KERSH M E.Rat bone properties and their relationship to gait during growth[J].J Exp Biol,2019,222(Pt 18):jeb203554.
[10] 张洪,鲍波.浅谈国内BALB/c小鼠及KM小鼠的基本生物学特性[J].中国实用医药,2010,5(3):252-254.
[11] BATOON L,MILLARD S M,RAGGATT L J,et al.Osteal macrophages support osteoclast-mediated resorption and contribute to bone pathology in a postmenopausal osteoporosis mouse model[J].J Bone Miner Res,2021,36(11):2214-2228.
[12] WANG L,DING Y Y,WU Y Q,et al.Koumine ameliorates neuroinflammation by regulating microglia polarization via activation of Nrf2/HO-1 pathway[J].Biomed Pharmacother,2023,167:115608.
[13] YANG L,ZHANG B,LIU J,et al.Protective effect of acteo-side on ovariectomy-induced bone loss in mice[J]. Int J Mol Sci,2019,20(12):2974.
[14] 王起家,李可大,张江.骨质疏松动物模型研究进展[J].实用中医内科杂志,2023,37(9):134-138.
[15] KONG J Y,SU F Q,LIU Y,et al.The pharmacokinetics of buserelin after intramuscular administration in pigs and cows[J].BMC Vet Res,2022,18(1):136.
[16] 尹航,董博,康武林,等.补肾复方在绝经后骨质疏松症动物模型中的研究进展[J].中医药导报,2022,28(9):110-113.
[17] 周丹妮,卫若楠,康梦娇,等.围绝经期综合征动物模型研究进展[J].中国实验方剂学杂志,2021,27(18):243-250.
[18] BRENT M B.Pharmaceutical treatment of bone loss:from animal models and drug development to future treatment strategies[J].Pharmacol Ther,2023,244:108383.
[19] THOMPSON D D,SIMMONS H A,PIRIE C M,et al.FDA guidelines and animal models for osteoporosis[J].Bone,1995,17(4 Suppl):125S-133S.
[20] BONJOUR J P,AMMANN P,RIZZOLI R.Importance of preclinical studies in the development of drugs for treatment of osteoporosis:a review related to the 1998 WHO guidelines[J].Osteoporos Int,1999,9(5):379-393.
[21] 马艳芳,张鑫,李慧,等.骨质疏松症动物模型中大鼠卵巢切除手术要点及其术后护理[J].实验动物科学,2022,39(3):57-62.
[22] 李明,吕厚辰,尹鹏滨,等.两种卵巢切除术式建立大鼠骨质疏松模型的优势比较[J].解放军医学院学报,2015,36(4):383-387.
[23] KARAM N,LAVOIE J F,ST-JACQUES B,et al.Bone-specific overexpression of PITX1 induces senile osteoporosis in mice through deficient self-renewal of mesenchymal progenitors and Wnt pathway inhibition[J].Sci Rep,2019,9(1):3544.
[24] TANAKA T,TAKAHASHI A,KOBAYASHI Y,et al.Foxf2 represses bone formation via Wnt2b/β-catenin signaling[J].Exp Mol Med,2022,54(6):753-764.
[25] XU R,SHEN X,XIE H,et al.Identification of the canonical and noncanonical role of miR-143/145 in estrogen-deficient bone loss[J].Theranostics,2021,11(11):5491-5510.
[26] MELANIE V,ARKADIUSZ O,SABRINA S,et al.An antagonistic monoclonal anti-Plexin-B1 antibody exerts therapeutic effects in mouse models of postmenopausal osteoporosis and multiple sclerosis[J]. J Biol Chem,2022,298(9):102265.
[27] NI X,WU B,LI S,et al.Equol exerts a protective effect on postmenopausal osteoporosis by upregulating OPG/RANKL pathway[J].Phytomedicine,2023,108:154509.
[28] 付晓宁,胡朝晖.骨代谢生化指标对于骨质疏松症诊断与治疗的临床意义[J].中国骨与关节损伤杂志,2018,33(9):1003-1005.
[29] 刘蔚楠,周晓霞,朱玮,等.益肾健骨膏对去卵巢骨质疏松大鼠骨代谢的影响[J].中国骨质疏松杂志,2022,28(6):857-862.
[30] ZHANG J,ZHANG Q,LIU H,et al.Soy-whey dual-protein alleviates osteoporosis of ovariectomized rats via regulating bone fat metabolism through gut-liver-bone axis[J].Nutrition,2022,103/104:111723.
[31] LARRAÑAGA-VERA A, TOTI K S, FLATOW J S,et al.Novel alendronate-CGS21680 conjugate reduces bone resorption and induces new bone formation in post-menopausal osteoporosis and inflammatory osteolysis mouse models[J]. Arthritis Res Ther,2022,24(1):265.
[32] 刘文静,杨娟,张楚天,等.巴戟天抗去卵巢骨质疏松大鼠的血清代谢组分析[J].中国药理学通报,2022,38(3):446-453.
[33] 叶维建,李国山,黄建芳.甲状旁腺激素对绝经后骨质疏松大鼠骨密度和骨生物力学的影响[J].中国老年学杂志,2022,42(8):1991-1994.
[34] ZHENG L,ZHUANG Z,LI Y,et al.Bone targeting antioxidative nano-iron oxide for treating postmenopausal osteoporosis[J].Bioact Mater,2022,14:250-261.
[35] 许勇,谢贤斐,颜威,等.木犀草素调控PI3K/AKT通路改善绝经后骨质疏松症大鼠模型骨丢失的机制[J].热带医学杂志,2022,22(5):639-643.
[36] 文枝,于慧,龙琼,等.基于药效成分比较研究山萸肉酒制前后分别配伍入六味地黄汤对绝经后骨质疏松症模型大鼠的干预作用[J/OL].世界科学技术-中医药现代化,2023[2023-12-1]. https://link.cnki.net/urlid/11.5699.r.20231123.1644.004.
[37] ZHOU E,XIANG D,YU B,et al.Ovarian tissue transplantation ameliorates osteoporosis and dyslipidaemia in ovariectomised mice[J].J Ovarian Res,2022,15(1):139.
[38] ZHAO Y,XU Y,ZHENG H,et al.QingYan formula extracts protect against postmenopausal osteoporosis in ovariectomized rat model via active ER-dependent MEK/ERK and PI3K/Akt signal pathways[J].J Ethnopharmacol,2021,268:113644.
[39] TAO H,LI W,ZHANG W,et al.Urolithin A suppresses RANKL-induced osteoclastogenesis and postmenopausal osteoporosis by,suppresses inflammation and downstream NF-κB activated pyroptosis pathways[J].Pharmacol Res,2021,174:105967.
[40] 凌家艳,刘庆,马威,等.补肾通络方对去势大鼠骨质疏松症模型子宫内膜和骨量流失的影响[J].中医药导报,2022,28(6):20-23.
相似文献/References:
[1]李林军.应用膨胀式椎弓根螺钉内固定治疗合并骨质疏松的
胸腰椎退行性疾病[J].中医正骨,2015,27(08):49.
[2]李学朋,朱立国.骨疏康胶囊对去卵巢大鼠骨小梁的影响[J].中医正骨,2015,27(12):12.
LI Xuepeng,ZHU Liguo.Effect of Gushukang Jiaonang(骨疏康胶囊)on bone trabecula in the ovariectomized rats[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(12):12.
[3]陈冠军,陈扬,庄汝杰.可灌注骨水泥椎弓根螺钉系统
在老年腰椎疾患手术中的应用[J].中医正骨,2015,27(02):40.
[4]王丹辉,贲越,韩梅.林蛙油治疗绝经后骨质疏松症的临床研究[J].中医正骨,2014,26(01):27.
Wang Danhui*,Ben Yue,Han Mei..Clinical study of Rana temporaria oil in the treatment of postmenopausal osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2014,26(12):27.
[5]黄建华,黄建武,李慧辉,等.加味左归丸对绝经后骨质疏松症肝肾不足证
患者骨密度的影响[J].中医正骨,2013,25(11):19.
Huang Jianhua*,Huang Jianwu,Li Huihui,et al.Effect of JIAWEI ZUOGUI pill on bone mineral density in postmenopausal osteoporosis patients with deficiency of liver and kidney[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2013,25(12):19.
[6]项旻,杨虹,林爱菊,等.绝经后2型糖尿病患者骨质疏松与血微量元素的关系研究[J].中医正骨,2013,25(12):20.
Xiang Min*,Yang Hong,Lin Aiju,et al.Clinical study on the relationship between osteoporosis and serum trace elements levels in postmenopausal women with type 2 diabetes[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2013,25(12):20.
[7]史晓林,李春雯,张志强.弱阳离子磁珠分离技术和基质辅助激光解吸电离飞行时间质谱技术在原发性Ⅰ型骨质疏松症血清标志蛋白筛选中的应用[J].中医正骨,2014,26(03):5.
Shi Xiaolin*,Li Chunwen,Zhang Zhiqiang..Application of magnetic beads based weak cation exchange separation technology and matrix-assisted laser desorption-ionization time of flight mass spectrometry technology in screening serum protein markers of primary type-Ⅰ osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2014,26(12):5.
[8]李明,徐明雄,冯左基,等.自拟壮骨方治疗绝经后骨质疏松症的疗效及作用机制研究[J].中医正骨,2014,26(09):21.
Li Ming*,Xu Mingxiong,Feng Zuoji,et al.Study on the curative effect and mechanism of action of self-made ZHUANGGU decoction in treatment of postmenopausal osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2014,26(12):21.
[9]陈俊杰,李晴晴,夏瑢.脂代谢及血清内脂素水平与绝经后骨质疏松症的
相关性研究[J].中医正骨,2012,24(04):16.
CHEN Jun-jie*,LI Qing-qing,XIA Rong.*.Study on the correlations between the levels of lipid metabolism and serum visfatin and postmenopausal osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2012,24(12):16.
[10]许超,肖鲁伟,吴承亮.绝经后女性骨质疏松症辨证分型与抑郁焦虑的关系研究[J].中医正骨,2011,23(12):3.
XU Chao*,XIAO Lu-wei,WU Cheng-liang.*.Study on the relationship between the syndrome differ classification and the depression and anxiety for the postmenopausal women with osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2011,23(12):3.
[11]韩艳,温利平,刘娜,等.补肾活血方对去卵巢大鼠骨代谢及骨密度的影响[J].中医正骨,2015,27(12):7.
HAN Yan,WEN Liping,LIU Na,et al.Effect of Bushen Huoxue Fang(补肾活血方)on bone metabolism and bone mineral density in the ovariectomized rats[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(12):7.
[12]欧国峰,刘鑫,董博,等.绝经后骨质疏松症的免疫学研究进展[J].中医正骨,2016,28(08):70.
[13]施振宇,刘钟,陈文亮,等.中医综合疗法防治绝经后骨量减少的多中心临床研究[J].中医正骨,2017,29(04):1.
SHI Zhenyu,LIU Zhong,CHEN Wenliang,et al.A multicenter clinical study of complex therapy of traditional Chinese medicine for prevention and treatment of postmenopausal osteopenia[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2017,29(12):1.
[14]梁文娜,李西海,李灿东.血清microRNA与绝经后骨质疏松症肾虚证的关系[J].中医正骨,2017,29(10):53.
[15]梁文娜,李西海,胡柳,等.二至丸抑制绝经后骨质疏松大鼠骨代谢紊乱的作用机制研究[J].中医正骨,2017,29(11):1.
LIANG Wenna,LI Xihai,HU Liu,et al.Study on mechanism of action of Erzhi Wan(二至丸)in inhibiting bone metabolism disorder in rats with postmenopausal osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2017,29(12):1.
[16]刘晨,李兴勇,姚兴璋,等.绝经后骨质疏松症的流行病学概况及发病机制研究进展[J].中医正骨,2018,30(03):52.
[17]杨依然,刘钟,毛一凡,等.酪蛋白激酶-2相互作用蛋白1基于磷脂酰肌醇3-激酶/蛋白激酶B/哺乳动物雷帕霉素靶蛋白通路参与绝经后骨质疏松症发生发展过程中细胞自噬的机制[J].中医正骨,2018,30(04):59.
[18]曹俊青,郑剑南,张麟.右归丸联合阿仑膦酸钠口服治疗绝经后骨质疏松症肾阳虚证的临床研究[J].中医正骨,2018,30(05):20.
CAO Junqing,ZHENG Jiannan,ZHANG Lin.A clinical study of oral application of Yougui Wan(右归丸)and alendronate sodium for treatment of postmenopausal osteoporosis with kidney-yang deficiency syndrome[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2018,30(12):20.
[19]李中万,徐绍俊,杨广钢,等.健肾方联合碳酸钙D3咀嚼片(Ⅱ)
治疗绝经后骨质疏松症肾阳虚证[J].中医正骨,2018,30(08):11.
LI Zhongwan,XU Shaojun,YANG Guanggang,et al.Oral application of Jianshen Fang(健肾方)and calcium carbonate and Vitamin D3 chewable tablets(Ⅱ)for treatment of postmenopausal osteoporosis with kidney-yang deficiency syndrome[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2018,30(12):11.
[20]赵凡,刘全,吴连国.口服强骨饮联合碳酸钙D3片治疗绝经后骨质疏松症的临床研究[J].中医正骨,2019,31(04):26.
ZHAO Fan,LIU Quan,WU Lianguo.Oral applications of Qianggu Yin(强骨饮)and calcium carbonate and Vitamin D3 tablets for treatment of postmenopausal osteoporosis:a clinical study[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2019,31(12):26.